Search

100% Optical

Johnson & Johnson spotlights its new contact lens at 100% Optical

The contact lens manufacturer has recently launched the Acuvue Oasys Max 1-Day Multifocal for Astigmatism

Contact lens manufacturer, Johnson & Johnson, placed a spotlight on its newly-launched daily disposable lens for patients with presbyopia and astigmatism at 100% Optical this year.

Speaking to OT about the Acuvue Oasys Max 1-Day Multifocal for Astigmatism, Mathilde Beau, Johnson & Johnson managing director for Western Europe, described the contact lens as a daily disposable multifocal toric lens as a first of its kind.

The design philosophy centres on simplicity for both practitioners and patients, Beau added.

According to optometrist and Johnson & Johnson professional education and development manager for the UK and Ireland, Robyn Marsden, the release of the contact lens has “opened up a whole category and area that I can fit patients with.”

Ease of use has been a central focus in the design of the lens, with data proving positive, shared optometrist and Johnson & Johnson professional affairs consultant, Faye McDearmid, who called the development “really exciting.”

In studies, the contact lens has been found to have around a 91% one fit success rate, and 93% in two fits or less, McDearmid said.

She explained: “The last thing that you want in a busy clinic is to be thinking, okay, so this lens is available, but what do I do again and how does it work?... but the feedback suggests that is the case.”

To support adoption, new digital tools have been introduced, including An Acuvue simplifit calculator and an Acuvue Astigmatism Demonstration Flipper, both of which have been designed to streamline fittings and improve patient understanding.

Presbyopia remains under-discussed, noted McDearmid, who explained: “This can be for a variety of reasons; it might be due to time pressures or a focus on other issues the patient is experiencing.”

However, it is essential for optometrists to prepare patients for this change in their vision and reassure them that effective options remain available, helping to prevent drop-out.

McDearmid shared: “I tend to start conversations with patients even before they reach this stage, discussing the changes they can expect in their vision and what we can do about them. It’s reassuring to be able to say: ‘You may be experiencing changes in your vision, but there are lenses that can still meet your needs and allow you to enjoy all the activities you value. Let’s find the right fit for you’.”

Advertisement